Trial record 1 of 1 for:    NCT00136019
Previous Study | Return to List | Next Study

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00136019
Recruitment Status : Completed
First Posted : August 26, 2005
Last Update Posted : September 22, 2014
Information provided by:
UCB Pharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2006
  Study Completion Date : August 2006
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):